{"id":80054,"date":"2026-04-28T12:05:28","date_gmt":"2026-04-28T12:05:28","guid":{"rendered":"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/"},"modified":"2026-04-28T12:05:28","modified_gmt":"2026-04-28T12:05:28","slug":"proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/","title":{"rendered":"Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics"},"content":{"rendered":"<div>\n<p>Vienna, Austria, April  28, 2026  (GLOBE NEWSWIRE) &#8212; <\/p>\n<ul type=\"disc\">\n<li>Proxygen announces two lead programs approaching clinical development, p300 and CDK12, addressing multiple cancer types<\/li>\n<\/ul>\n<p align=\"justify\"><b>Vienna, Austria, April 28, 2026 \u2013<\/b> Proxygen, a biotechnology company pioneering the discovery of molecular glue degraders and next-generation proximity-based therapeutics, today publicly announced the expansion of its platform beyond targeted protein degradation to access a broader range of induced proximity therapeutics, while advancing two lead molecular glue degrader programs toward clinical development.<\/p>\n<p align=\"justify\">Induced proximity drugs harness the cell\u2019s own machinery by bringing proteins into proximity to modulate disease biology, with the potential to access targets and mechanisms beyond the reach of traditional small-molecule pharmacology. While targeted protein degradation represents the first clinically validated application of this concept, the underlying principle enables a much broader set of therapeutic mechanisms<sup>1<\/sup>.<\/p>\n<p align=\"justify\">\u201cAt Proxygen we believe induced proximity represents one of the most powerful emerging paradigms in drug discovery,\u201d said <b>Bernd Boidol, Ph.D<\/b>., Chief Executive Officer of Proxygen. \u201cOur initial work in molecular glue degraders has established the mechanistic foundation and technical capabilities to expand into new proximity-based mechanisms, and we are now translating this expertise into a pipeline of differentiated programs. With two lead candidates advancing toward the clinic, we are entering an important phase of execution.\u201d<\/p>\n<p align=\"justify\">The Company\u2019s p300 molecular glue degrader is designed to induce degradation of the transcriptional co-activator p300, a key epigenetic regulator implicated in multiple cancers. The program explores targeted degradation as a differentiated modality to modulate p300 beyond conventional inhibition.<\/p>\n<p align=\"justify\">Proxygen\u2019s second lead candidate, CDK12, is a brain-penetrant glue degrader program designed to inactivate the transcriptional kinase CDK12, a target implicated in aggressive HER2-driven cancers and tumors with central nervous system involvement.<\/p>\n<p align=\"justify\">\u201cI am pleased to have joined Proxygen at such a transformative phase,\u201d said <b>Chiara Conti, Ph.D.<\/b>, Chief Scientific Officer of Proxygen. \u201cOur two lead glue degrader programs, p300 and CDK12, clearly illustrate the differentiated approach we are taking within the induced proximity therapeutics field, and over the next 12 to 18 months, our primary focus is advancing these programs toward development candidate nomination and IND-enabling studies.\u201d<\/p>\n<p align=\"justify\"><b>Expanding beyond degradation to unlock new proximity therapeutics<\/b><\/p>\n<p align=\"justify\">Proxygen has spent the past several years systematically identifying productive interactions between disease-relevant proteins and E3 ligases, building a discovery platform designed to uncover new proximity-driven mechanisms. This expertise positions the company to expand beyond degradation while continuing to advance its degrader pipeline.<\/p>\n<p align=\"justify\">\u201cTargeted degradation is only the beginning of what induced proximity can achieve,\u201d said <b>Georg Winter, Ph.D.<\/b>, founder and Chief Scientific Advisor of Proxygen, and a pioneer in the field. \u201cOur work focuses on understanding how to bring proteins together in ways that reprogram cellular biology, opening the door to entirely new therapeutic modalities.\u201d<\/p>\n<p align=\"justify\">Going forward, the Company will execute a dual strategy focused on advancing its lead molecular glue degrader programs toward development candidate nomination and IND-enabling studies, while expanding its pipeline beyond degradation.<\/p>\n<p align=\"justify\"><b>About Proxygen<\/b><\/p>\n<p align=\"justify\">Proxygen is a Vienna-based biotechnology company developing a new class of therapeutics based on induced proximity. Building on deep expertise in molecular glue degraders, the company is expanding into a broader range of proximity-inducing mechanisms to reprogram cellular biology and address high-value targets across oncology and beyond. Proxygen combines computational design, chemical biology, and functional genomics to systematically discover and develop proximity-based therapeutics.<\/p>\n<p><b>Contact<\/b><\/p>\n<p>Bernd Boidol, Ph.D.<br \/>Chief Executive Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_9Ce1XQNqltXIHY457qEvk0QyqRL-8mJg_btzFY-2KdKa6l3RerwFu2uUNDTMFYtLEH1G77q5jlOcEg_WNYtBffJq-3InhUJt9Z0c7nSBs_xN56VodNTMh3WM19johDo\" rel=\"nofollow\" target=\"_blank\" title=\"management@proxygen.com\">management@proxygen.com<\/a><\/p>\n<p><b>For media inquiries<\/b><\/p>\n<p>MC Services AG<\/p>\n<p>Anne Hennecke\/Lydia Robinson-Garc\u00eda, Ph.D.<br \/>Phone: +49 (0)170 7134018<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tn7FWVQWeu1hfFnml5cG_s6th9QCH_rJajtDWHvgK0HZafSekdMB16n9i_-KtqVsgJ8nbKvt_MEFamftkZSQ0CmgQKHAtJbXdPWSH3Zk-_k3TLiyVi1YhiIBU6lAA3EZ\" rel=\"nofollow\" target=\"_blank\" title=\"proxygen@mc-services.eu\">proxygen@mc-services.eu<\/a><\/p>\n<hr>\n<p><sup>1<\/sup> Segal, D. <i>et.al.<\/i> 2026. Leveraging the BAF chromatin remodeling complex for targeted transcriptional rewiring in cancer. bioRxiv preprint doi: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=E06MIrfxLPMmX5k4bb6Sz9ajS_Mh9OwadDWgS52hEvIHa-82C7-rpzpSXMVNwsKI8uEY0KD2KiPAzlEl3X6NWaHUrSYjdQF0NrhB11FSUc8MnWnOcG8ZZjcTIEHbg0TshPM-sgWHw46uti6umMjcbg==\" rel=\"nofollow\" target=\"_blank\" title=\"\">https:\/\/doi.org\/10.64898\/2026.03.30.715217<\/a><\/p>\n<p id=\"gnw_attachments_section-header\">\n    <strong>Attachment<\/strong>\n<\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n        <a target=\"_blank\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=6jOrYfBKoPsQDHPPVqTt9a1dzcxsJiRLgLYwPmL0GT8vjMo_wonlhtUaVPgWmNqqhva9lGruUmfVHG0uN7hzV6N-m7et3uD56-FPxVt5jokZYHR_hj9f5QGo81uFAk1El_mvlB5-6ZMTYPO3laaBXR3ENJtGwzXwiuUDy6PaPpB7pj3gqksZNmPo6Nwo9ljxdFw_h0G8GrLJLc0PMT5Ylvm2_8_09pxumNtD8ppvVyo=\" title=\"260428_Press Release_Proxygen_Corporate Update_Beyond Degradation_FINAL\" rel=\"nofollow\">260428_Press Release_Proxygen_Corporate Update_Beyond Degradation_FINAL<\/a>\n      <\/li>\n<\/ul>\n<pre>CONTACT: Contact\r\n\r\nBernd Boidol, Ph.D.\r\nChief Executive Officer\r\nmanagement@proxygen.com\r\n\r\nFor media inquiries\r\n\r\nMC Services AG\r\n\r\nAnne Hennecke\/Lydia Robinson-Garc\u00eda, Ph.D.\r\nPhone: +49 (0)170 7134018\r\nproxygen@mc-services.eu<\/pre>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NzkxZDllMzEtODIzOS00MTcyLTk4NzktZWI0ZmQzZmRiYjU0LTUwMDE1OTg2MC0yMDI2LTA0LTI4LWVu\/tiny\/Proxygen-GmbH.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Vienna, Austria, April 28, 2026 (GLOBE NEWSWIRE) &#8212; Proxygen announces two lead programs approaching clinical development, p300 and CDK12, addressing multiple cancer types Vienna, Austria, April 28, 2026 \u2013 Proxygen, a biotechnology company pioneering the discovery of molecular glue degraders and next-generation proximity-based therapeutics, today publicly announced the expansion of its platform beyond targeted protein [&#8230;]\n","protected":false},"author":1,"featured_media":80055,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-80054","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Vienna, Austria, April 28, 2026 (GLOBE NEWSWIRE) &#8212; Proxygen announces two lead programs approaching clinical development, p300 and CDK12, addres\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-28T12:05:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/04\/sgb-media-kit-2026.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1075\" \/>\n\t<meta property=\"og:image:height\" content=\"716\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics\",\"datePublished\":\"2026-04-28T12:05:28+00:00\",\"dateModified\":\"2026-04-28T12:05:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/\"},\"wordCount\":615,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/\",\"name\":\"Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2026-04-28T12:05:28+00:00\",\"dateModified\":\"2026-04-28T12:05:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics","og_description":"Vienna, Austria, April 28, 2026 (GLOBE NEWSWIRE) &#8212; Proxygen announces two lead programs approaching clinical development, p300 and CDK12, addres","og_url":"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2026-04-28T12:05:28+00:00","og_image":[{"width":1075,"height":716,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/04\/sgb-media-kit-2026.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics","datePublished":"2026-04-28T12:05:28+00:00","dateModified":"2026-04-28T12:05:28+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/"},"wordCount":615,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/","url":"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/","name":"Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2026-04-28T12:05:28+00:00","dateModified":"2026-04-28T12:05:28+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/80054","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=80054"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/80054\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/80055"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=80054"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=80054"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=80054"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}